Anaphylaxis and Allergic Reaction – Adult

For pediatric see, “Allergic Reaction and Anaphylaxis – Pediatric”

Criteria

  • Anaphylaxis is a rapidly progressing, life threatening allergic reaction, not simply a rash or hives

All levels

  • Allow the patient to maintain position of comfort
  • Airway management and appropriate oxygen therapy
  • Ongoing assessment of the effectiveness of breathing
  • See Respiratory Arrest / Failure – Adult if necessary
  • If severe respiratory distress, facial or oral edema, and/or hypoperfusion
  • OR
  • If patient has a history of anaphylaxis and has an exposure to an allergen developing respiratory distress and/or hypoperfusion and/or rash:
  • Epinephrine (1 mg/mL) 0.3 mg IM‡¹
  • If the patient does not improve within 5 minutes, may repeat once

EMT and up

  • If wheezing, Albuterol² 2.5 mg via nebulizer; may repeat to a total of three doses‡
  • May be combined with Ipratropium (Atrovent) 0.5 mg in 2.5 mL (unit dose)‡

AEMT and up

  • Vascular access as appropriate
  • Normal Saline 500 mL bolus, if SBP <100 mmHg or MAP <65 mmHg; may repeat up to a total of 2 L if lung sounds remain clear
  • Goal SBP >100 mmHg and MAP >65 mmHg

CC and up

  • For signs of allergic reaction, including, but not limited to rash, itching, nausea, etc, consider:
  • Diphenhydramine (Benadryl) 50 mg IV or IM
  • Dexamethasone (Decadron) 10 mg PO, IM, or IV

Paramedic

  • Epinephrine infusion starting at 5 mcg/min titrated to MAP >65 mmHg or SBP >100 mmHgⓟ

Medical control

  • Additional Albuterol
  • Additional Epinephrine for levels with limited standing orders
  • Additional IV fluid

Key points

  • 1. Epinephrine 0.3 mg may be administered via Adult Autoinjector (CFR or higher) or Syringe Epinephrine Kit (EMT or higher)
  • 2. A combination unit dose (such as a DuoNeb®) may be substituted for Albuterol 2.5 mg in 3 mL (unit dose) & Ipratropium (Atrovent) 0.5 mg in 2.5 mL (unit dose) mixed together
  • If Epinephrine is administered by crew or patient self-administered Epinephrine, regional procedure may require consulting medical control prior to honoring a request for refusal of medical care
  • Though a previous history of anaphylaxis is an important indicator for treatment, providers should be aware that anaphylaxis may develop in patients with no prior history
  • Anaphylaxis may present with shock associated only with GI symptoms. In the setting of a known exposure to an allergen associated with shock, nausea, vomiting, abdominal pain, and/or diarrhea, consider anaphylaxis in consult with medical control.